IL6 and neoplasm: In the present study, tumor growth combined with IF and IHC data using VEGF, Ki-67, and CD31 staining, suggest that the IL-6–silencing vector slowed tumor regrowth and attenuated the aggressive behavior of the orthotopic tumor model, which were associated with decreased STAT3 activation, cell proliferation and angiogenesis following irradiation.